Google Übersetzer
Appili Therapeutics Inc Class A
About
Appili Therapeutics Inc Class A — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 30 2026
Appili Therapeutics to Exhibit at World Vaccine Congress Washington
Feb 18 2026
Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement
Feb 12 2026
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
Dec 18 2025
Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement
Dec 15 2025
The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Contract from NIH/NIAID